Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
As per available reports about 31 Relevant Journals, 6 Conferences and 7 National Symposium are presently dedicated exclusively to Head and Neck Oncology and about 35 Open Access Articles are being published on Head and Neck Oncology.
Head and Neck Cancer refers to a group of biologically similar cancers that start in the lip, oral cavity (mouth), nasal cavity (inside the nose), paranasal sinuses, pharynx , and larynx. 90% of head and neck cancers are squamous cell carcinomas (HNSCC), Squamous cell carcinoma (SCC) is the most frequent malignant tumor of the head and neck region. HNSCC is the sixth leading cancer by incidence worldwide. There are 0.5 million new cases a year worldwide. Two thirds occur in industrialized nations. HNSCC usually develops in males in the 6th and 7th decade. The five-year survival rate of patients with HNSCC is about 40-50% originating from the mucosal lining (epithelium) of these regions. Head and neck cancers often spread to the lymph nodes of the neck, and this is often the first (and sometimes only) sign of the disease at the time of diagnosis. Head and neck cancer is strongly associated with certain environmental and lifestyle risk factors, including tobacco smoking, alcohol consumption, UV light, particular chemicals used in certain workplaces, and certain strains of viruses, such as human papillomavirus. These cancers are frequently aggressive in their biologic behaviour; patients with these types of cancer are at a higher risk of developing another cancer in the head and neck area. Head and neck cancer is highly curable if detected early, usually with some form of surgery, but radiation therapy may also play an important role, while chemotherapy is often ineffective.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
This conference is aimed to give each and every detailed score about the scientific traditionalism and optimism to the citizen and consumer to remain aware of Head and Neck cancers and its symptoms at every age of their life. Scientist will also give fruitful information about various types of head and neck cancers like Throat cancers, Salivary Gland cancers, Neck cancers, Nose and Sinus cancer, Orbital tumours, Distant Metastasis etc.
ConferenceSeries Cordially invites Oncologist, Cancers researchers, and other health-care professionals, scientists and students working in the field across the globe to participate in the Head and Neck Oncology conference, where all the recent advancement and researches in the field of Head and Neck Cancers will be discussed under a single roof. Head and Neck Oncology will be an excellent amalgamation of academia and industry as it involves every aspects of empirical and conceptual thinking in exploring new dimensions in this field. It is open to all types of research methodologies both from academia and industry.
Market Analysis:
The global head and neck cancer diagnostics market is expected to grow from $6.19 billion in 2014 to an estimated $12.6 billion by 2020, at a CAGR of 12.67%. Overall, head and neck cancer accounts for more than 550,000 cases annually (roughly 3 -5 % of all cancer incidences) worldwide. Males are affected significantly more than females with a ratio ranging from 2:1 to 4:1. The market for head and neck cancer diagnostics is expected to increase year on year correlating with rising incidence of the disease in most regions. Head and neck cancer accounts for 47,000 new cases (3% of all new cancer cases and 2% of all cancer deaths) in the United States annually; it is the fifth most common malignancy worldwide (an estimated 644,000 new cases annually).
International Symposium and Workshop:
• 1st International Symposium on Tumor-Host Interaction in Head and Neck Cancer in conjunction with the 5th Annual Meeting on Experimental and Translational Head and Neck Oncology, January 22–24, 2015 – Essen, Germany
• International Symposium on Head and Neck tumors Translation from Cancer Biology to Cancer Medicine, October 3-4 2015, T M A Pai, conference Hall, Manipal University
• International workshop in head and neck cancer management, Budapest, Hungary, 1 November 2014
List of best International Conferences
1. 3rd Rhinology and Otology Conference
April 25-27, 2016, UAE
2. Oral, Mouth and Throat Cancer Conference
August 18-20, 2016, USA
3. Pancreatic and Colorectal Cancer Cancer
March 29-30, 2016, USA
4. 4th Blood Malignancies and Treatment Conference
April 18-20, 2016, UAE
5. 2nd Prostate Cancer and Treatment Conference
May 05-07, 2016, USA
6. Gynecologic Oncology Conference
May 19-21, 2016, USA
7. 2nd Antimicrobial Agents and Chemotherapy Conference
June 06-07, 2016, USA
8. 10th Global Annual Oncologists Meeting
July 11-13, 2016, Germany
9. 11th Asia-Pacific Oncologists Annual Meeting
July 11-13, 2016, Malaysia
10. Melanoma and Carcinoma Summit
July 14-15, 2016, Australia
11. Pediatric Oncology Conference
August 04-06, 2016, Canada
12. Cervical Cancer Conference
September 22-23, 2016, Austria
13. Global Cancer Therapy Conference
November 03-05, 2015, Spain
14. 13th Cancer Therapy Global Summit
October 17-19, 2016, UAE
15. Mesothelioma Conference
November 03-04, 2016, Spain
16. Leukemia and Bone marrow Transplantation Conference
November 10-12, 2016, Turkey
17. 6th Cancer Therapy World Congress
December 01-03, 2016, USA
18. Cancer Diagnostics Conference & Expo
June 13-15, 2016, Italy
19. 7th European Conference on Head and Neck Oncology (ECHNO), Istanbul on 27-30 April, 2016
20. 5th Trends in Head and Neck Oncology, Lisbon, Portugal, November 5 - 7, 2015
21. Multidisciplinary Head and Neck Cancer Symposium, February 18-20, Scottsdale, Arizona
22. 9th International Conference on Head and Neck Cancer,July 16 - 20, 2016 Washington, USA
Relevant Society and Associations
1. American Head and Neck Society
2. Head and Neck Cancer Alliance
3. National Cancer Institute
4. Cancer Council Australia
5. Cancer Institute NSW
6. The Oral Cancer Foundation
7. Mouth Cancer Foundation
8. Support for People with Oral and Head and Neck Cancer (SPOHNC)
9. EHNS-European Head & Neck Society
10. International Federation of Head & Neck Oncologic Societies
11. Australian and New Zealand Head and Neck Cancer Society
12. Korean Society of Head and Neck Surgery
13. Italian Society of Otolaryngology Head Neck Surgery
14. European Association for Cranio-Maxilo-Facial Surgery
15. Argentine Association of Head and Neck Surgery(AACCyC)
16. Brazilian Society of Head and Neck Surgery (BSHNS)
17. British Association of Head and Neck Oncologists
18. International Association of Oral Pathologists (IAOP)
19. AAOMS (American Association of Oral and Maxillofacial Surgeons)
20. The Foundation for Head and Neck Oncology
Companies
1. BioVex Inc
2. AstraZeneca
3. VentiRx Pharmaceutical
4. ERBITUX®
5. Frost & Sullivan
6. Norgine
7. Azanta
8. Marsala Biotech Inc
9. Genetronics Biomedical Corporation
10. The MedPulser®
11. Biocon
12. Cetuximab
13. Kite Pharma (KITE)
14. Merck Serono Australia Pty Ltd
15. FiercePharma.
16. Clovis Oncology Inc.
17. Pfizer
18. Cancer and Toxic Chemicals | PSR
19. Roche
20. Novartis
21. Johnson & Johnson
22. Biogen Idec
This page will be updated regularly.
This page was last updated on November 5, 2024
